[1]
|
McCord, J.M. (1996) Effects of positive iron status at a cellular level. Nutrition Reviews, 54, 85-86.
doi:10.1111/j.1753-4887.1996.tb03876.x
|
[2]
|
Beutler, E., Hoffbrand, A.V. and Cook, J.D. (2003) Iron deficiency and overload. The American Society of Hematology, 2003, 40-61.
|
[3]
|
Nishida, Y. (2004) Oxidative stress and neurodegeneration. Medical Hypotheses and Research, 1, 227-245.
|
[4]
|
Harrison, P.M. and Arosio, P. (1996) The ferritin: Molecular properties, iron storage function and cellular regulation. Biochimica et Biophysica Acta, 1275, 161-203.
doi:10.1016/0005-2728(96)00022-9
|
[5]
|
Chasteen, N.D. and Harrison, P.M. (1999) Meneralization in ferritin: An efficient means of iron storage. Journal of Structural Biology, 126, 182-194.
doi:10.1006/jsbi.1999.4118
|
[6]
|
Dresow, B., Petersen, D., Fischer, R. and Nielson, P. (2008) Non-transferin-bound iron in plasma following administration of oral iron drugs. Biometals, 21, 273-276.
doi:10.1007/s10534-007-9116-5
|
[7]
|
Evans, R.W., Rafique, R., Zarea, A., Rapisarda, C., Cammack, R., Evans, P.J., Porter, J.B. and Hider, R.C. (2008) Nature of non-transferrin-bound iron: Studies on iron citrate compelxes and thelassemic sera. Journal of Biological Inorganic Chemistry, 13, 57-74.
doi:10.1007/s00775-007-0297-8
|
[8]
|
Hershko, C., Link, G., Konjin, A. and Cabantchik, Z.I. (2005) Objectives and mechanism of iron chelation therapy. Annals of the New York Academy of Sciences, 1054, 124-135. doi:10.1196/annals.1345.015
|
[9]
|
Nishida, Y., Ito, S., Okuno, T. and Ohba, S. (1997) New insight into reaction of iron(III)-peroxide adduct with alkanes: An alternative model for cytochrome P-450 and methane monooxygenase. Zeitschrift fur Naturforschung, 52C, 615-622.
|
[10]
|
Nishida, Y. (1998) Important role of substrate in activation of dioxygen in biological oxygenases. Trends in Inorganic Chemistry, 5, 89-103.
|
[11]
|
Li, J.-L., Okada, S., Hamazaki, S., Ebina, Y. and Midorikawa, O. (1987) Nephrotoxicity and it prevention by vitamin E in ferric nitrilotriacetate-promoted lipid peroxidation. Biochimica et Biophysica Acta, 922, 28-33.
doi:10.1016/0005-2760(87)90241-4
|
[12]
|
Kawabata, T., Ma, Y., Yamadori, I. and Okada, S. (1997) Ironinduced apotosis in mouse renal proximal tubules after an injection of a renal carcinogen, iron-nitrilotriacetate. Carcinogenesis, 18, 1389-1398.
doi:10.1093/carcin/18.7.1389
|
[13]
|
Mizuno, R., Kawabata, T., Sutoh, Y., Nishida, Y. and Okada, S. (2006) Oxidative renal tubular injuries induced by amino-carboxylate-type iron(III) coordination compound as candidate renal carcinogens. Biometals, 19, 675-683. doi:10.1007/s10534-006-9004-4
|
[14]
|
Halliwell, B. and Gutteridge, J.M.C. (1985) Free Radicals in Biology and Medicine, Oxford University Press, London.
|
[15]
|
Nishida, Y., Goto, A., Akamatsu, T., Ohba, S., Fujita, T. and Okada, S. (1994) Iron chelates in biological systems: Its relevance to induction of pathogenesis of tissue damage and carcinogenesis. Chemistry Letters, 1994, 641-644. doi:10.1246/cl.1994.641
|
[16]
|
Nishida, Y. and Ito, S. (1995) Structures and reactivity of several iron(III) complexes in the presence of hydrogen peroxide: Relevance to induction of tissue damage caused by iron(III) chelates in rats. Polyhedron, 14, 2301-2308.
doi:10.1016/0277-5387(95)00109-6
|
[17]
|
Nishida, Y. and Akamatsu, T. (1992) Formation of active oxygen species due to presence of binuclear iorn(III) compound. J. Act. Oxyg. Free Rad., 3, 376-383.
|
[18]
|
Nishida, Y. and Takeuchi, M. (1987) Unique reactivity of peroxide ion trapped in binuclear iron(III) complex. Zeitschrift fur Naturforschung, 42b, 52-54.
|
[19]
|
Nishino, S., Hosomi, H., Ohba, S., Matsushima, H., Tokii, T. and Nishida, Y. (1999) Selective dioxygenation of cyclohexane catalyzed by hydrogen peroxide and dinuclear iron(III) complexes with m-alkoxo bridge. Journal of the Chemical Society, Dalton Transactions, 1999, 1509-1515.
doi:10.1039/a809725i
|
[20]
|
Nishida, Y., Itoh, Y. and Satoh, T. (2007) Origin of renal proximal tubular injuries by Fe(III)-nta chelate. Zeitschrift fur Naturforschung, 62c, 608-612.
|
[21]
|
Nishida, Y. (2009) Structural characteristics of iron(III) chelates to induce tissue damage and renal carcinoma; chemical origin of the iron toxicity. TCIMail, 141, 1-15.
|
[22]
|
Lippard, S.J., Schugar, H. and Walling, C. (1967) The crystal and molecular structure of an oxo-bridged binuclear iron(III) compelx, [(Hedta)FeO(Hedta)]2-. Inorganic Chemistry, 6, 1825-1831. doi:10.1021/ic50056a015
|
[23]
|
Okada, S., Minamiyama, Y., Hamazaki, S., Toyokuni, S. and Sotomatsu, A. (1993) Glutathione cycle dependency of ferric nitrilotriacetate-induced lipid peroxidation in mouse proximal renal tubules. Archives of Biochemistry and Biophysics, 301, 138-142.
doi:10.1006/abbi.1993.1125
|
[24]
|
Heath, S.L. and Powell, A.K. (1992) The trapping of iron hydroxide unit by the ligand “Heidi”: Two new hydroxo(oxo)iron chelates containing 19 and 17 iron atoms. Angewandte Chemie, International Edition in English, 31, 191-193. doi:10.1002/anie.199201911
|
[25]
|
Nishino, S., Kunita, M., Kobayashi, T., Matsushima, H., Tokii, T. and Nishida, Y. (1999) Interaction between the peroxide adduct of binuclear iron(III) complex with (HTTP) anion and the sugar moiety of nucleosides. Zeitschrift fur Naturforschung, 54b, 1272-1276.
|
[26]
|
Bates, G.W. and Schlabach, M.R. (1973) The reaction of ferric salts with transferrin. The Journal of Biological Chemistry, 248, 3228-3232.
|
[27]
|
Nishida, Y. and Yamada, K. (1990) Lipoxygenase-like function of some binuclear iron(III) compounds. Journal of the Chemical Society, Dalton Transactions, 1990, 3639-3641. doi:10.1039/dt9900003639
|
[28]
|
Nishida, Y., Takeuchi, M., Shimo, H. and Kida, S. (1985) Synthesis and reactivity of binuclear iron(III) complexes with ligands composed of two trident chelating groups. Inorganica Chimica Acta, 96, 115-120.
doi:10.1016/S0020-1693(00)93746-0
|
[29]
|
Nishida, Y., Nasu, M. and Akamatsu, T. (1992) Reaction between binuclear iron(III) compounds and DMPO. Journal of the Chemical Society, Chemical Communications, 1992, 93-94. doi:10.1039/c39920000093
|
[30]
|
Gaeta, A. and Hider, R.C. (2005) The crucial role of metal ions in neurodegeneration: The basis for a promising therapeutic strategy. British Journal of Pharmacology, 146, 1041-1059.
|
[31]
|
Bush, A.I. (2003) The metallobiology of Alzheimer’s disease. Trends in Neurosciences, 26, 207-214.
doi:10.1016/S0166-2236(03)00067-5
|
[32]
|
Satoh, T., Abe, K. and Nishida, (2012) Oxidase-like function by apotransferrin towards Manganese(III) chelates. International Journal of Chemistry, 4, 10-15.
doi:10.5539/ijc.v4n3p10
|
[33]
|
Yoshida, K., Kaneko, K., Miyajima, H., Tokuda, T., Nakamura, A., Kato, M. and Ikeda, S. (2000) Increased lipid peroxidation in the brains of aceruplasminemia patients. Journal of the Neurological Sciences, 175, 91-95.
doi:10.1016/S0022-510X(00)00295-1
|
[34]
|
Sutoh, Y., Okawamukai, Y., Nishino, S. and Nishida, Y. (2006) Structure of a new tetranuclear iron(III) complex with an oxo-bridge; factors to govern formation and stability of oxo-bridged iron(III) species in the L-subunit of ferritin. Zeitschrift fur Naturforschung, 61c, 149-154.
|
[35]
|
Andersson, M.E., Hogbom, M., R.-Matthis, A., Andersson, K.K., Sjoberg, B. and Nortlund, P. (1999) The crystal structure of an azide complex of the differous R2 subunit of ribonucleotide reductase displays a novel carboxylate shift with important mechanistic implication for diiron-catalayzed oxygen activation. Journal of the American Chemical Society, 121, 2346-2352.
doi:10.1021/ja982280c
|
[36]
|
Baik, M., Newcome, M., Friesner, R.A. and Lippard, S.J. (2003) Mechanistic studies on the hydroxylation of methane by methane monooxygenase. Chemical Reviews, 103, 2385-2419. doi:10.1021/cr950244f
|
[37]
|
Nishino, S., Takahashi, Y. and Nishida, Y. (2002) Important role of hydrogen peroxide for storing of iron ion in human L-subunit ferritin. Inorganic Chemistry Communications, 5, 609-611. doi:10.1016/S1387-7003(02)00509-9
|
[38]
|
Kato, J., Fujikawa, K., Kanda, M., Fukuda, N., Sasaki, K., Takayama, T., Kobune, K., Takada, K., Takimoto, R., Hamada, H., Ikeda, T. and Niitsu, Y. (2001) A mutation, in the iron-responsive element of H-ferritin mRNA, causing autosomal dominant iron overload. The American Journal of Human Genetics, 69, 191-197. doi:10.1086/321261
|
[39]
|
Levi, S., Girelli, D., Perrone, F., Pasti, M., Beaumont, C., Corrocher, R., Albertini, A. and Arosio, P. (1998) Analysis of ferritins in lymphoblastoid cell lines and in the lens of subjects with hereditary hyperferritinemia-cataract syndrome. Blood, 91, 4180-4187.
|
[40]
|
Curtis, A.R., Fey, C., Morris, C.M., Bindoff, L.A., Patrick, P.G., Chinnery, P.F., Coulthard, A., Jackson, M.J., Jackson, A.P., McHale, D.P., Hay, D., Barker, W.A., Markham, A.F., Bates, D., Curtis, A. and Burn, J. (2001) Mutation in the gene region encoding basal ganglia disease. Nature Genetics, 28, 350-354. doi:10.1038/ng571
|
[41]
|
Kakuda, T., Suzuki, Y. and Ikeda, I. (2011) Prevent effect of Tea catechins against lifestyle-related disease. FFI Journal, 216, 346-355.
|
[42]
|
Hider, R.C., Ma, Y., M.-Holgado, F., Gaeta, A. and Roy, S. (2008) Iron chelation as a potential therapy for neurode-gehetaive disease. Biochemical Society Transactions, 36, 1304-1308. doi:10.1042/BST0361304
|
[43]
|
Okawamukai, Y., Sutoh, Y. and Nishida, Y. (2006) Deposition of iron(III) hydroxide on aggregations of several proteins. Synthesis and Reactivity in Inorganic and Metal-Organic, and Nano-Metal Chemistry, 36, 373-375.
|
[44]
|
Nishino, S., Kobayashi, T., Matsushima, H., Tokii, T. and Nishida, Y. (2006) Enhanced nucleophilicity and depresssed electrophilicity of peroxide ion by zinc(II), Aluminum(III) and Lanthanum(III) ion. Zeitschrift fur Naturforschung, 56c, 138-143.
|
[45]
|
Moccegiani, E., Bertoni-Freddari, C., Marcellini, F. and Malavolta, M. (2005) Brain, aging and neurodegeneration: Role of zinc ion availability. Progress in Neurobiology, 75, 367-390. doi:10.1016/j.pneurobio.2005.04.005
|
[46]
|
Kayed. R., Head, E., Thompson, J.L., McIntire, T.M., Milton, S.C., Cotman, C.W. and Glabe, C.G. (2003) Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science, 300, 486-489.
doi:10.1126/science.1079469
|
[47]
|
Klein, W.L., Stine, W.B. Jr. and Teplow, D.B. (2004) Small assemblies of unmodified amyloid b-protein are the proximate neurotoxin in Alzheimer’s disease. Neurobiology of Aging, 25, 569-580.
|
[48]
|
Grabrucker, A.M., Roman, M. and Garner, C.C. (2011) Brain-delivery of zincions as potential treatement for neurological diseases: Mini review. Drug Delivery Letters, 1, 13-23. doi:10.2174/2210304x11101010013
|
[49]
|
Haysishi, O. (2005) An odyssey with oxygen. Biochemical and Biophysical Research Communications, 338, 2-6.
doi:10.1016/j.bbrc.2005.09.019
|
[50]
|
Nishida, Y. (2011) The chemical process of oxidative stress by copper(II) and iron(III) ions in several neuro-degenerative disorders. Monatshefte für Chemie, 142, 375-384.
|